Maintenance of Clinical Efficacy and Radiographic Benefit Through Two Years of Ustekinumab Therapy in Patients With Active Psoriatic Arthritis: Results From a Randomized, Placebo‐Controlled Phase III Trial

Maintenance of Clinical Efficacy and Radiographic Benefit Through Two Years of Ustekinumab Therapy in Patients With Active Psoriatic Arthritis: Results From a Randomized, Placebo‐Controlled Phase III Trial

Bibliographic Details
Main Authors: Kavanaugh, Arthur, Puig, Lluís, Gottlieb, Alice B., Ritchlin, Christopher, Li, Shu, Wang, Yuhua, Mendelsohn, Alan M., Song, Michael, Zhu, Yaowei, Rahman, Proton, McInnes, Iain B.
Format: Online
Language:English
Published: John Wiley and Sons Inc. 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5063124/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5063124/

Similar Items